熔点	138-142 ºC

危险品标志	Xn
危险类别码	R36/37/38;R68
安全说明书	S26;S37/39

来源	SDS样本
Alfa-Aesar	浏览或下载
Sigma-Aldrich	浏览或下载
TCI	浏览或下载

产品合成路线

更多

名称	CAS号

更多

文章

同行评议文献

A case of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) related to rufinamide.S Shahbaz et al.Dermatology online journal, 19(4), 4-4 (2013-09-12) [Efficacy and safety of levetiracetam as adjunctive therapy in Japanese children with uncontrolled partial-onset seizures: multicenter and open-label study (N01223), short term evaluation].Hidefumi Nakamura et al.Brain and nerve = Shinkei kenkyu no shinpo, 65(9), 1083-1092 (2013-09-11) Valproic acid, but not levetiracetam, selectively decreases HDAC7 and HDAC2 expression in human ovarian cancer cells.Patrycja Kwiecińska et al.Toxicology letters, 224(2), 225-232 (2013-11-10) Anticonvulsants for fibromyalgia.Nurcan Üçeyler et al.The Cochrane database of systematic reviews, 10(10), CD010782-CD010782 (2013-10-17) A new concept affecting restoration of inflammation-reactive astrocytes.L Block et al.Neuroscience, 250, 536-545 (2013-07-31) Early-onset absence epilepsy aggravated by valproic acid: a video-EEG report.Vincenzo Belcastro et al.Epileptic disorders : international epilepsy journal with videotape, 15(4), 440-443 (2013-10-31) Results of phase II levetiracetam trial following acute head injury in children at risk for posttraumatic epilepsy.Phillip L Pearl et al.Epilepsia, 54(9), e135-e137 (2013-07-24) Levetiracetam compared with valproic acid for the prevention of postoperative seizures after supratentorial tumor surgery: a retrospective chart review.Young Jin Lee et al.CNS drugs, 27(9), 753-759 (2013-08-08) [Efficacy and psychiatric adverse events as short-term adjunctive levetiracetam for epileptic children with refractory convulsive seizures].Kuniaki Iyoda et al.No to hattatsu = Brain and development, 45(6), 463-464 (2013-12-10) [Epileptic encephalopathy associated with forced normalization after administration of levetiracetam].Takahiro Kikuchi et al.No to hattatsu = Brain and development, 45(5), 375-378 (2013-11-12) Efficacy and safety of pregabalin versus levetiracetam as adjunctive therapy in patients with partial seizures: a randomized, double-blind, noninferiority trial.Gaetano Zaccara et al.Epilepsia, 55(7), 1048-1057 (2014-06-07) Antihyperalgesic/antinociceptive effects of ceftriaxone and its synergistic interactions with different analgesics in inflammatory pain in rodents.Radica M Stepanovic-Petrovic et al.Anesthesiology, 120(3), 737-750 (2013-09-28) The effects of levetiracetam on neural tube development in the early stage of chick embryos.Yahya Guvenc et al.Turkish neurosurgery, 23(5), 617-622 (2013-10-09) Additional antiepileptic mechanisms of levetiracetam in lithium-pilocarpine treated rats.Muhammad Y Al-Shorbagy et al.PloS one, 8(10), e76735-e76735 (2013-10-08) Antiepileptic drugs and neurocognitive development.Pavel Klein et al.Neurology, 82(3), 194-195 (2014-01-10) The safety and tolerability of different intravenous administrations of levetiracetam, bolus versus infusion, in intensive care unit patients.Evren Burakgazi et al.Clinical EEG and neuroscience, 45(2), 89-91 (2013-12-21) Inhibition of excitatory synaptic transmission in hippocampal neurons by levetiracetam involves Zn²⁺-dependent GABA type A receptor-mediated presynaptic modulation.Masahito Wakita et al.The Journal of pharmacology and experimental therapeutics, 348(2), 246-259 (2013-11-22) A simple assay for determination of levetiracetam in rat dried blood spots by LC-MS/MS.Wenxia Luo et al.Bioanalysis, 5(15), 1843-1851 (2013-08-03) Postanoxic myoclonus: two case presentations and review of medical management.Adrian Budhram et al.Archives of physical medicine and rehabilitation, 95(3), 588-590 (2013-09-26) Memory retrieval deficits: alleviation by etiracetam, a nootropic drug.S J Sara Psychopharmacology, 68(3), 235-241 (1980-01-01) Augmented renal clearance of vancomycin and levetiracetam in a traumatic brain injury patient.Aaron M Cook et al.Neurocritical care, 19(2), 210-214 (2013-08-03) Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy.Dong Wook Kim et al.Epilepsia, 54(10), e146-e149 (2013-08-29) The established status epilepticus trial 2013.Thomas Bleck et al.Epilepsia, 54 Suppl 6, 89-92 (2013-09-06) Levetiracetam versus (fos)phenytoin for seizure prophylaxis in pediatric patients with intracranial hemorrhage.Seema Bansal et al.Journal of neurosurgery. Pediatrics, 13(2), 209-215 (2013-11-30) In utero exposure to levetiracetam vs valproate: development and language at 3 years of age.R Shallcross et al.Neurology, 82(3), 213-221 (2014-01-10) Can zinc depletion play a role in LEV-induced hair loss? Considerations from a case study.Rocco Salvatore Calabrò et al.Epilepsy & behavior : E&B, 29(1), 254-255 (2013-08-14) The long-term efficacy and safety of levetiracetam in a tertiary epilepsy centre.Bong Su Kang et al.Epileptic disorders : international epilepsy journal with videotape, 15(3), 302-310 (2013-08-29)

备注